During the perioperative phase, obese patients face an elevated susceptibility to surgical site infections stemming from anatomical changes, compromised immune response, and underlying health conditions. While antibiotic prophylaxis stands as a pivotal measure in surgical site infection prevention, managing its efficacy in obese individuals poses unique challenges. Factors like altered pharmacokinetics, dosing complexities, and heightened antimicrobial resistance potential necessitate tailored approaches.